Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
David B. Kaysen currently holds 51,000 shares of Sun BioPharma, Inc. (SNBP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David B. Kaysen has been a net seller of SNBP stock. They have purchased $68.9K and sold $521.2K worth of shares.
David B. Kaysen's most recent insider trade was on May 16, 2018, when they purchased 1,000 shares at $0.00 per share.
David B. Kaysen serves as Executive at Sun BioPharma, Inc. (SNBP). They have executed 15 insider transactions totaling $590.1K over their tenure at the company.
David B. Kaysen holds the position of Executive at Sun BioPharma, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
David B. Kaysen has shown a selling trading pattern, with $68.9K in total purchases and $521.2K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by David B. Kaysen was on May 11, 2006, when they sold $408.9K worth of ZVXI shares. This transaction involved 17,580 shares at $23.26 per share.
David B. Kaysen currently owns 51,000 shares of Sun BioPharma, Inc. (SNBP), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of David B. Kaysen's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. David B. Kaysen has 15 Form 4 filings on record as an insider at Sun BioPharma, Inc..
Set alerts for David B. Kaysen and 40,000+ other insiders.